2023 / 03

Next Paper
DOI: 10.47183/mes.2023.040

REVIEW

Current understanding of epidemiology and pathogenesis of multisystem inflammatory syndrome associated with SARS-CoV-2 in children

Konstantinova YuE1, Vilnits AA1,2, Bekhtereva MK1,2, Alekseeva LA1, Glotov OS1, Egorova ES1
About authors

1 Pediatric Research and Clinical Center of Infectious Diseases of the Federal Medical Biological Agency, Saint Petersburg, Russia

2 Saint Petersburg State Pediatric Medical University, Saint-Petersburg, Russia

Correspondence should be addressed: Yulia E. Konstantinova
Professora Popova, 9, Saint Petersburg, 197022, Russia; ur.liam@32avonitnatsnok.ailuy

About paper

Author contribution: Konstantinova YuE, Alekseeva LA, Glotov OS, Egorova ES — search for literature, manuscript writing and editing, approval of the final version of the article; Vilnitz AA, Bekhtereva MK — concept development, search for literature, manuscript writing and editing, approval of the final version of the article.

Received: 2023-08-25 Accepted: 2023-09-10 Published online: 2023-09-30
|
  1. Dufort EM, Koumans EH, Chow EJ, Rosenthal EM, Muse A, Rowlands J, et al. Multisystem inflammatory syndrome in children in New York State. N Engl J Med. 2020; 383 (4): 347–58.
  2. Feldstein LR, Tenforde MW, Friedman KG, Newhams M, Rose EB, Dapul H, et al. Characteristics and outcomes of US children and adolescents with multisystem inflammatory syndrome in children (MIS-C) compared with severe acute COVID-19. Jama. 2021; 325 (11): 1074–87.
  3. CDC [Internet]. Information for Healthcare Providers about Multisystem Inflammatory Syndrome in Children (MIS-C) [cited 2023 Jul 29]. Available from: https://www.cdc.gov/mis/ MIS-C/hcp_cstecdc/index.html.
  4. Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020; 395 (10237): 1607–8.
  5. Kunal S, Ish P, Sakthivel P, Malhotra N, Gupta K. The emerging threat of multisystem inflammatory syndrome in adults (MIS-A) in COVID-19: a systematic review. Heart & Lung. 2022; (54): 7–18.
  6. Shaiba LA, More K, Hadid A, Almaghrabi R, Al Marri M, Alnamnakani M, et al. Multisystemic inflammatory syndrome in neonates: a systematic review. Neonatology. 2022; 119 (4): 405–17.
  7. World Health Organization, et al. Multisystem inflammatory syndrome in children and adolescents with COVID-19: scientific brief. 2020 May 15. World Health Organization. 2020. Available from: WHO/2019-nCoV/Sci_Brief/Multisystem_Syndrome_ Children/2020.1.
  8. Metodicheskie rekomendacii "Osobennosti klinicheskih projavlenij i lechenija zabolevanija, vyzvannogo novoj koronavirusnoj infekciej (COVID-19) u detej. Versija 2 (03.07.2020)", utv. Minzdravom Rossii. Russian.
  9. CDC [Internet]. Health Department-Reported Cases of Multisystem Inflammatory Syndrome in Children (MIS-C) in the United States [cited 2023 Jul 29]. Available from: https://covid.cdc.gov/covid-data-tracker/#mis-national-surveillance.
  10. Jiang L, Tang K, Levin M, Irfan O, Morris SK, Wilson K, et al. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020; 20 (11): 276–88.
  11. Sadykov MN, Ziatdinov VB, Reshetnikova ID, Hakimov NM, Lopushov DV, Isaeva GSh. Izuchenie urovnja i struktury populjacionnogo immuniteta k SARS-CoV2 u naselenija Respubliki Tatarstan v period vtorogo pika rasprostranenija COVID-19. Jepidemiologija i vakcinoprofilaktika. 2021; 20 (5): 39–51. Russian.
  12. Hoste L, Van Paemel R, Haerynck F. Multisystem inflammatory syndrome in children related to COVID-19: a systematic review. Eur J Pediatr. 2021; (180): 2019–34.
  13. Kostik MM, Bregel LV, Avrusin IS, Dondurei EA, Matyunova AE, Efremova OS, et al. Distinguishing between multisystem inflammatory syndrome associated with COVID-19 in children and the Kawasaki disease: development of preliminary criteria based on the data of the retrospective Multicenter Cohort Study. Front Pediatr. 2021; (9): 787353.
  14. Diwakar K, Sarangi T, Srivastava P, Tanti SK, Swaroop S. Human adenovirus infection causing hyperinflammatory syndrome mimicking multisystem inflammatory syndrome in children (MIS-C): a case report. Cureus. 2023; 15 (6): e40239.
  15. Fabi M, Dondi A, Andreozzi L, Frazzoni L, Biserni GB, Ghiazza F, et al. Kawasaki disease, multisystem inflammatory syndrome in children, and adenoviral infection: a scoring system to guide differential diagnosis. Eur J Pediatr. 2023 Aug 19. Available from: https://link.springer.com/article/10.1007/s00431-023-05142-6.
  16. Spivack T, Chawla R, Marik PE. Epstein-Barr virus-associated hemophagocytic syndrome mimicking severe sepsis. J Emerg Trauma Shock. 2008; 1 (2): 119–22.
  17. Ramaswamy A, Brodsky NN, Sumida TS, Comi M, Asashima H, Hoehn KB, et al. Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children. Immunity. 2021; 54 (5): 1083–95.
  18. Rapid Risk Assessment. Paediatric inflammatory multisystem syndrome and SARS-CoV-2 infection in children. European Centre for Disease Prevention and Control. 2020.
  19. El Tal T, Morin MP, Morris SK, Farrar DS, Berard RA, Kakkar F, et al. Paediatric inflammatory multisystem syndrome in Canada: population-based surveillance and role of SARS-CoV-2 linkage. Pediatr Res. 2023 Jun 5: 1–10. Available from: https://www. nature.com/articles/s41390-023-02668-1.
  20. Cohen JM, Carter MJ, Cheung CR, Ladhani S. Lower risk of multisystem inflammatory syndrome in children with the delta and omicron variants of severe acute respiratory syndrome coronavirus 2. Clinical Infectious Diseases. 2023; 76 (3): 518–21.
  21. Lopez L, Burgner D, Glover C, Carr J, Clark J, Boast A, et al. Lower risk of multi-system inflammatory syndrome in children (MIS-C) with the omicron variant. Lancet Reg Health West Pac. 2022; (27): 100604.
  22. Lopez L, Burgner D, Glover C, Carr J, Clark J, Boast A, et al. Corrigendum to “Lower risk of multi-system inflammatory syndrome in children (MIS-C) with the omicron variant”. Lancet Reg Health West Pac. 2023; (35): 100808.
  23. Skudarnov EV, Vyhodceva GI, Novikova LM, Maljuga OM, Kirichjok EJu, Skudarnova AP, et al. Kliniko-laboratornye aspekty mul'tisistemnogo vospalitel'nogo sindroma, associirovannogo s COVID-19 u detej. Bjulleten' medicinskoj nauki. 2022; 2 (26): 61–6. Russian.
  24. Avtandiljan LL, Fedulova AA, Parazjan AS, Arzumanjan AI, Gadzhiahmedova JeI. Klinicheskij sluchaj: mul'tisistemnyj vospalitel'nyj sindrom u detej, associirovannyj s COVID-19. Universum: medicina i farmakologija. 2021; 6 (78): 7–11. Russian.
  25. Lobzin JuV, Vilnic AA, Kostik MM, Behtereva MK, Uskov AN, Skripchenko NV, et al. Pediatricheskij mul'tisistemnyj vospalitel'nyj sindrom, associirovannyj s novoj koronavirusnoj infekciej: nereshennye problemy. Zhurnal infektologii. 2021; 13 (1): 13–20. Russian.
  26. Kostik MM, Bregel LV, Avrusin IS, Efremova OS, Belozerov KE, Dondurei EA, et al. Heart involvement in multisystem inflammatory syndrome, associated with COVID-19 in children: the retrospective multicenter cohort data. Front Pediatr. 2022; (10): 829420.
  27. Lee PI, Hsueh PR. Multisystem inflammatory syndrome in children: A dysregulated autoimmune disorder following COVID-19. J Microbiol Immunol Infect. 2023; (56): 236–45.
  28. Filippatos F, Tatsi EB, Michos A. Immunology of multisystem inflammatory syndrome after COVID-19 in children: a review of the current evidence. Int J Mol Sci. 2023; 24 (6): 5711.
  29. Osmanov IM, Hegaj IM, Trunina II, Chebotareva TA, Cheburkin AA, Shumilov PV. Immunopatogenez mul'tisistemnogo vospalitel'nogo sindroma, svjazannogo s COVID-19, u detej. Immunologija. 2022; 43 (2): 217–23. Russian.
  30. Dubrovina JuA, Legonkova TI, Vodneva LM, Shtykova ON, Shpakovskaja KS, Melnikova VM, Artjomenkova EI. Mul'tisistemnyj vospalitel'nyj sindrom u detej, perenesshih COVID-19. Vestnik Smolenskoj gosudarstvennoj medicinskoj akademii. 2022; 21 (3): 133–41. Russian.
  31. Hacuk AS, Romanova KR, Samodova OV. Mul'tisistemnyj vospalitel'nyj sindrom, associirovannyj s SARS-CoV-2, u detej: jetiopatogenez, klinicheskaja kartina, diagnostika, lechenie (obzor). Zhurnal mediko-biologicheskih issledovanij. 2022; 10 (4), 371–9. Russian.
  32. Lee WS, Wheatley AK, Kent SJ, DeKosky BJ. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020; 5 (10): 1185–91.
  33. Katzelnick LC, Gresh L, Halloran ME, Mercado JC, Kuan G, Gordon A, et al. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017; 358 (6365): 929–32.
  34. Khan S, Siddique R, Shereen MA, Ali A, Liu J, Bai Q, et al. Emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2: biology and therapeutic options. J Clin Microbiol. 2020; 58 (5): 00187-20.
  35. Noval Rivas M, Porritt RA, Cheng MH, Bahar I, Arditi M, et al. Multisystem inflammatory syndrome in children and long COVID: the SARS-CoV-2 viral superantigen hypothesis. Front Immunol. 2022; (13): 941009.
  36. Porritt RA, Paschold L, Rivas MN, Cheng MH, Yonker LM, Chandnani H, et al. HLA class I-associated expansion of TRBV112 T cells in multisystem inflammatory syndrome in children. J Clin Invest. 2021; 131 (10): 146614.
  37. Yonker LM, Gilboa T, Ogata AF, Senussi Y, Lazarovits R, Boribong BP, et al. Multisystem inflammatory syndrome in children is driven by zonulin-dependent loss of gut mucosal barrier. J Clin Invest. 2021; 131 (14): 149633.
  38. Moreews M, Le Gouge K, Khaldi-Plassart S, Pescarmona R, Mathieu AL, Malcus C, et al. Polyclonal expansion of TCR Vβ 21.3+ CD4+ and CD8+ T cells is a hallmark of multisystem inflammatory syndrome in children. Sci Immunol. 2021; 6 (59): eabh1516.
  39. Malik A, Tóth EN, Teng MS, Hurst J, Watt E, Wise L, et al. Distorted TCR repertoires define multisystem inflammatory syndrome in children. PLoS One. 2022; 17 (10): 274–89.
  40. Benamar M, Chen Q, Chou J, Julé AM, Boudra R, Contini P, et al. The Notch1/CD22 signaling axis disrupts Treg function in SARS-CoV-2–associated multisystem inflammatory syndrome in children. J Clin Invest. 2023; 133 (1): 163235.
  41. Khor CC, Davila S, Breunis WB, Lee YC, Shimizu C, Wright VJ, et al. Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease. Nat Genet. 2011; 43 (12): 1241–6.
  42. Diorio C, Henrickson SE, Vella LA, McNerney KO, Chase J, Burudpakdee C, et al. Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS–CoV2. J Clin Invest. 2020; 130 (11): 5967–75.
  43. Zou H, Lu J, Liu J, Wong JHY, Cheng S, Li Q, et al. Characteristics of pediatric multi-system inflammatory syndrome (PMIS) associated with COVID-19: a meta-analysis and insights into pathogenesis. Int J Infect Dis. 2021; (102): 319–26.
  44. Bautista-Rodriguez C, Sanchez-de-Toledo J, Clark BC, Herberg J, Bajolle F, Randanne PC, et al. Multisystem inflammatory syndrome in children: an international survey. Pediatrics. 2021; 147 (2): e2020024554.
  45. Sharma C, Ganigara M, Galeotti C, Burns J, Berganza FM, Hayes DA, et al. Multisystem inflammatory syndrome in children and Kawasaki disease: a critical comparison. Nat Rev Rheumatol. 2021; 17 (12): 731–48.
  46. Ouldali N, Pouletty M, Mariani P, Beyler C, Blachier A, Bonacorsi S, et al. Emergence of Kawasaki disease related to SARS-CoV-2 infection in an epicentre of the French COVID-19 epidemic: a time-series analysis. Lancet Child Adolesc Health. 2020; 4 (9): 662–8.
  47. Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. 2020; 183 (4): 968-981.
  48. Porritt RA, Binek A, Paschold L, Rivas MN, McArdle A, Yonker LM, et al. The autoimmune signature of hyperinflammatory multisystem inflammatory syndrome in children. J Clin Invest. 2021; 131 (20): e151520.
  49. Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Сell. 2020; 181 (2): 271–80.
  50. Zhou T, Tsybovsky Y, Gorman J, Rapp M, Cerutti G, Chuang GY, et al. Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains. Cell host & microbe. 2020; 28 (6): 867–79.
  51. Shikov AE, Barbitoff YA, Glotov AS, Danilova MM, Tonyan ZN, Nasykhova YA, et al. Analysis of the spectrum of ACE2 variation suggests a possible influence of rare and common variants on susceptibility to COVID-19 and severity of outcome. Front Genet. 2020; (11): 551220.
  52. Zhao Y, Patel J, Huang Y, Yin L, Tang L. Cardiac markers of multisystem inflammatory syndrome in children (MIS-C) in COVID-19 patients: a meta-analysis. Am J Emerg Med. 2021; (49): 62–70.
  53. Ahmed M, Advani S, Moreira A, Zoretic S, Martinez J, Chorath K, et al. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine. 2020; (26):100527.
  54. Blondiaux E, Parisot P, Redheuil A, Tzaroukian L, Levy Y, Sileo C, et al. Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19. Radiology. 2020; 297 (3): 283–8.
  55. Jain E, Donowitz JR, Aarons E, Marshall BC, Miller MP, et al. Multisystem inflammatory syndrome in children after SARS-CoV-2 vaccination. Emerging Infectious Diseases. 2022; 28 (5): 990–3.
  56. Nygaard U, Holm M, Hartling UB, Glenthøj J, Schmidt LS, Nordly SB, et al. Incidence and clinical phenotype of multisystem inflammatory syndrome in children after infection with the SARSCoV-2 delta variant by vaccination status: a Danish nationwide prospective cohort study. Lancet Child Adolesc Health. 2022; 6 (7): 459–65.
  57. Hoste L, Soriano-Arandes A, Buddingh EP, Whittaker E, Belot A, Ulloa-Gutierrez R, et al. Severe acute respiratory syndrome coronavirus 2 vaccination in children with a history of multisystem inflammatory syndrome in children: an international survey. J Pediatr. 2022; (248): 114–18.